Guidelines on the management of abnormal liver blood tests.
Guidelines on the management of abnormal liver blood tests.
复制标题
DOI：
10.1136/gutjnl-2017-314924
复制
发表时间：
2018-01
期刊：
影响因子：
24.5
通讯作者：
Yeoman A
中科院分区：
文献类型：
--
作者：
Newsome PN;Cramb R;Davison SM;Dillon JF;Foulerton M;Godfrey EM;Hall R;Harrower U;Hudson M;Langford A;Mackie A;Mitchell-Thain R;Sennett K;Sheron NC;Verne J;Walmsley M;Yeoman A
这些关于异常肝脏血液检查管理的最新指南已由英国胃肠病学会（BSG）的临床服务和标准委员会（CSSC）在BSG肝脏部分的主持下委托。本文件所取代的原指导原则于2000年编写，并由指导原则制定小组（GDG）成员进行了广泛的修订。GDG由患者/护理人员团体的代表组成（英国肝脏信托，Liver4life，PBC基金会和PSC支持），BSG肝脏部分的当选成员（包括来自苏格兰和威尔士的代表）、英国肝脏研究协会（BASL）、临床生物化学专家咨询委员会/皇家病理学院和临床生物化学协会、英国儿科胃肠病学会、肝病学和营养学（BSPGHAN）、英格兰公共卫生（实施和筛选）、皇家全科医学院、英国胃肠和腹部放射科医师学会（BSGAR）和急性医学学会。使用AGREE II工具评估证据质量和建议分级。这些指导方针具体涉及初级和二级保健中儿童和成人肝脏血液检查异常的管理，包括以下子标题：（1）什么构成肝脏血液检查异常？(2)什么是标准的肝脏血液测试面板？(3)什么时候应该检查肝脏血液检查？(4)肝脏血液检查异常的程度和持续时间是否决定随后的调查？(5)对肝脏血液检查异常的反应。它们的设计目的不是处理潜在肝脏疾病的管理。
These updated guidelines on the management of abnormal liver blood tests have been commissioned by the Clinical Services and Standards Committee (CSSC) of the British Society of Gastroenterology (BSG) under the auspices of the liver section of the BSG. The original guidelines, which this document supersedes, were written in 2000 and have undergone extensive revision by members of the Guidelines Development Group (GDG). The GDG comprises representatives from patient/carer groups (British Liver Trust, Liver4life, PBC Foundation and PSC Support), elected members of the BSG liver section (including representatives from Scotland and Wales), British Association for the Study of the Liver (BASL), Specialist Advisory Committee in Clinical Biochemistry/Royal College of Pathology and Association for Clinical Biochemistry, British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN), Public Health England (implementation and screening), Royal College of General Practice, British Society of Gastrointestinal and Abdominal Radiologists (BSGAR) and Society of Acute Medicine. The quality of evidence and grading of recommendations was appraised using the AGREE II tool. These guidelines deal specifically with the management of abnormal liver blood tests in children and adults in both primary and secondary care under the following subheadings: (1) What constitutes an abnormal liver blood test? (2) What constitutes a standard liver blood test panel? (3) When should liver blood tests be checked? (4) Does the extent and duration of abnormal liver blood tests determine subsequent investigation? (5) Response to abnormal liver blood tests. They are not designed to deal with the management of the underlying liver disease.
登录
查看更多内容
影响因子：
9.8
作者：
Daniel, S;Ben-Menachem, T;Blumenkehl, M
通讯作者：
Blumenkehl, M
影响因子：
2.9
作者：
Arnold, David T.;Bentham, Louise M.;Girling, Alan J.
通讯作者：
Girling, Alan J.
影响因子：
29.4
作者：
Chalasani, Naga;Younossi, Zobair;Sanyal, Arun J.
通讯作者：
Sanyal, Arun J.
影响因子：
25.7
作者：
Armstrong, Matthew J.;Houlihan, Diarmaid D.;Newsome, Philip N.
通讯作者：
Newsome, Philip N.
影响因子：
25.7
作者：
Boursier, Jerome;Vergniol, Julien;de Ledinghen, Victor
通讯作者：
de Ledinghen, Victor